Granular 发表于 2025-3-30 08:42:59

Biomarkers in Breast Carcinomas,., and ., have enabled clinicians to detect underlying genetic alterations, develop novel therapeutic approaches, and predict therapy response in these patients. Nevertheless, in order to improve prognosis and survival of these patients, accurate application and correct evaluation of molecular alter

sacrum 发表于 2025-3-30 13:48:54

http://reply.papertrans.cn/19/1879/187808/187808_52.png

半圆凿 发表于 2025-3-30 17:24:27

Diagnostic Approach According to Uncovered Metastatic Sites: Mediastinum-Thymus, Peritoneum, Centraemical panel including mesothelial markers such as calretinin and D2-40, a Müllerian marker such as PAX-8, ER, and epithelial markers such as Ber-EP4 and MOC-31 are useful. Additionally, homozygous deletion of BRCA1-associated protein 1(BAP-1) or p16 detected by FISH is specific for peritoneal mesot

semble 发表于 2025-3-30 23:36:28

http://reply.papertrans.cn/19/1879/187808/187808_54.png

kyphoplasty 发表于 2025-3-31 01:46:35

http://reply.papertrans.cn/19/1879/187808/187808_55.png

合同 发表于 2025-3-31 07:42:57

http://reply.papertrans.cn/19/1879/187808/187808_56.png

Credence 发表于 2025-3-31 10:09:56

http://reply.papertrans.cn/19/1879/187808/187808_57.png

integral 发表于 2025-3-31 14:19:26

http://reply.papertrans.cn/19/1879/187808/187808_58.png
页: 1 2 3 4 5 [6]
查看完整版本: Titlebook: Biomarkers in Carcinoma of Unknown Primary; Sulen Sarioglu,Ozgul Sagol,Anil Aysal Book 2022 The Editor(s) (if applicable) and The Author(s